Bio-Rad Laboratories, Inc. (BIO)
NYSE: BIO · Real-Time Price · USD
269.06
-2.24 (-0.83%)
Feb 23, 2026, 12:09 PM EST - Market open

Bio-Rad Laboratories Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Feb '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
7,2628,2129,1829,39912,46022,439
Market Cap Growth
-26.09%-10.57%-2.31%-24.57%-44.47%29.37%
Enterprise Value
7,1678,1898,9489,04611,98921,328
Last Close Price
271.30302.99328.51322.89420.49755.57
PE Ratio
9.6410.81---5.28
Forward PE
26.1328.9428.8526.5128.6659.87
PS Ratio
2.833.183.583.524.457.68
PB Ratio
0.981.101.401.081.301.64
P/TBV Ratio
1.091.231.571.171.401.72
P/FCF Ratio
19.5521.9231.7143.08152.7041.88
P/OCF Ratio
13.7615.4320.1725.0764.1033.52
PEG Ratio
-2.712.712.712.714.28
EV/Sales Ratio
2.773.173.493.394.287.30
EV/EBITDA Ratio
16.6118.9820.2317.6819.3430.37
EV/EBIT Ratio
26.9330.7730.7724.7424.8437.77
EV/FCF Ratio
19.1321.8630.9041.46146.9339.81
Debt / Equity Ratio
0.190.190.210.160.140.02
Debt / EBITDA Ratio
2.782.782.692.442.050.30
Debt / FCF Ratio
3.703.704.756.4417.010.42
Net Debt / Equity Ratio
-0.02-0.02-0.04-0.02-0.04-0.05
Net Debt / EBITDA Ratio
-0.36-0.36-0.65-0.39-0.65-0.92
Net Debt / FCF Ratio
-0.42-0.42-1.00-0.92-4.93-1.21
Asset Turnover
0.260.260.240.210.180.19
Inventory Turnover
1.651.651.521.651.912.11
Quick Ratio
3.893.894.554.034.041.90
Current Ratio
5.625.626.485.835.552.92
Return on Equity (ROE)
10.84%10.84%-24.09%-6.94%-31.14%36.11%
Return on Assets (ROA)
1.67%1.67%1.68%1.77%1.93%2.29%
Return on Invested Capital (ROIC)
2.90%2.99%3.92%4.12%4.34%3.98%
Return on Capital Employed (ROCE)
2.60%2.60%3.30%3.10%3.70%3.30%
Earnings Yield
10.38%9.25%-20.08%-6.78%-29.11%18.96%
FCF Yield
5.12%4.56%3.15%2.32%0.66%2.39%
Buyback Yield / Dilution
3.31%3.31%3.41%1.93%1.40%-0.16%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q